- Provide a review of new information on the basic pathophysiology of ventricular arrhythmias.
- Provide an in-depth understanding of current management strategies used for the care of ventricular arrhythmias in various disease states, including non-pharmacological therapies such as implantable device and catheter ablation techniques.
At the conclusion of this symposium, participants should be able to:
- Describe the science critical to the understanding and treatment of ventricular arrhythmias including:
- Biophysics of ablation
- Anatomic substrate for ventricular tachycardia (VT)
- Review the current status and future role for implantable cardioverter defibrillators (ICD) in the management of sudden cardiac death
- Discuss the role of new techniques for VT substrate assessment including functional scar imaging, intra-procedure MRI, and high density mapping
- Describe risk stratification and treatment including VT ablation in patients with arrhythmogenic right ventricular cardiomyopathy
- Explain strategies to improve treatment outcome in patients with ventricular arrhythmias and structural heart disease including “bail out” strategies after failed catheter ablation
- Review the current use/role of antiarrhythmic drug therapy for ventricular arrhythmias
- Describe and manage complications of VT ablation
- Identify techniques to improve ablation success for idiopathic arrhythmias including use of advanced imaging
- Describe the status of ongoing multicenter VT-related trials and discuss which questions need to be answered by trials in the future